First RSV vaccines inch closer to the finish line
Pfizer Inc and GSK are close to bringing the first two vaccines for RSV to the United States after gaining the backing of a panel of advisers to the FDA.
New Search
If you are not happy with the results below please do another search
Search
50 search results for:
ICU Medical to compete against GE Healthcare for Medtronic units – sources
/in TherapeuticsICU Medical has teamed up with a private equity firm to challenge GE Healthcare Technologies in its pursuit of two medical technology businesses that Medtronic Plc is seeking to sell for between $8 billion and $9 billion, according to people familiar with the process.
Positive Phase III builds case for Intra-Cellular’s depression drug
/in TherapeuticsIntra-Cellular Therapies’ Caplyta (lumateperone) met its primary endpoint in its Phase III trial, easing the burden of depressive episodes in patients with major depressive disorder (MDD) or bipolar depression with mixed features.
J&J bows out of RSV vaccine race after scrapping trial
/in TherapeuticsThe company is discontinuing the late-stage study of its experimental respiratory syncytial virus adult vaccine, weeks after rivals Pfizer and GSK gained a lead in the race for the first vaccine against the virus.
US FDA approves first OTC opioid overdose reversal drug
/in TherapeuticsThe approval for OTC use of the naloxone-based nasal spray will help align the federal government’s stance with states that have provisions to offer the drug without prescription at pharmacies.
WHO to consider adding obesity drugs to ‘essential’ medicines list
/in TherapeuticsThe request to consider obesity drugs was submitted by three doctors and a researcher in the United States and covers the active ingredient liraglutide in Novo Nordisk’s obesity drug Saxenda, which will come off patent soon, allowing for cheaper generic versions.
Healthcare Businesswomen’s Association appoints Mary Stutts as chief executive officer
/in Marketing & AdvertisingMary Stutts becomes HBA’s first woman of color CEO. Incoming HBA CEO prioritizes preparing women for c-suite and corporate board roles and advancing global health equity.
Evotec up for potential $4B More in lucrative BMS partnership
/in Business, TherapeuticsBristol Myers Squibb is expanding its strategic collaboration with German partner Evotec for eight more years to discover and develop treatments for neurodegenerative diseases.
U.S. FDA panel to discuss Perrigo’s daily OTC birth-control pill in May
/in TherapeuticsThe panel will decide on recommending the non-estrogen contraceptive as a daily OTC birth control pill on May 9 and 10. The drug, Opill, is expected to be the first such pill in the United States if approved.
WHO revises COVID-19 vaccine recommendations for Omicron-era
/in TherapeuticsToday the World Health Organization changed its recommendations for COVID-19 vaccines, suggesting that high-risk populations should receive an additional dose 12 months after their last booster.